Search results
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 2 days agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 1 day agoOn Friday, Moderna Inc. MRNA announced that it has submitted an FDA application for review of its...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 3 days agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Colorado Springs Gazette· 3 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 3 days agoNovavax shares have gained nearly 40% over the past five days, boosted by COVID-19 headlines....
COVID Shots for JN.1 Variant Neutralize Newer Strains, Vaccine Makers Say
US News & World Report· 3 days agoFood and Drug Administration's advisers on Wednesday. The FDA panel will vote to recommend if companies should target the JN.1 variant when the companies update their vaccines for 2024-25 immunization ...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Colorado Springs Gazette· 1 day agoThe Food and Drug Administration's advisory is in line with European and World Health Organization recommendations and comes after the agency's advisers on Wednesday overwhelmingly backed the ...
From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained
The Conversation· 4 days agoMore than 16,000 Australians will be diagnosed with melanoma each year. Over the past decade, these treatments have seen a significant climb in the number of advanced melanoma patients surviving ...